Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
hearX Group developed a suite of clinically validated digital products for hearing loss detection, diagnosis, and intervention. Their solutions are used globally for early detection and management of hearing impairment. The company’s Lexie brand became the #1 OTC hearing aid in the U.S., with millions reached worldwide. In March 2025, hearX Group merged with Eargo to form a new combined company called LXE Hearing, focused on over-the-counter (OTC) hearing aid markets primarily in the US but also serving global needs through its legacy B2B/B2G channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on hearX Group.